COMPLIANCE OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS: 5-YEARS FOLLOW-UP OF THE RUSSIAN FAMILIAL HYPERCHOLESTEROLEMIA REGISTRY

被引:0
|
作者
Chubykina, U. [1 ]
Ezhov, M. [1 ]
Shaposhnik, I. [2 ]
Genkel, V. [2 ]
Ershova, A. [3 ]
Gurevich, V. [4 ]
Filippov, A. [5 ]
Voevoda, M. [6 ]
机构
[1] Minist Hlth, FSBI Natl Med Res Ctr Cardiol EI Chazov, Lab Lipid Disorders, Moscow, Russia
[2] South Ural State Med Univ, Cardiol, Chelyabinsk, Russia
[3] Natl Med Res Ctr Therapy & Prevent Med, Lab Clinom, Moscow, Russia
[4] St Petersburg State Univ, Ctr Atherosclerosis & Lipid Disorders, St Petersburg, Russia
[5] St Petersburg State Univ, Cardiol, St Petersburg, Russia
[6] IIPM, Cardiol, Novosibirsk, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P264
引用
收藏
页码:S84 / S84
页数:1
相关论文
共 50 条
  • [11] Five years follow-up of a patient with domino liver transplantation for familial hypercholesterolemia
    Popescu, Irinel
    Tulbure, Dan
    Gheorghe, Liana
    Mihaila, Mariana
    Hrehoret, Doina
    Brasoveanu, Vlad
    Vidu, Viorica
    Matei, Emil
    Iacob, Speranta
    Dima, Simona
    TRANSPLANT INTERNATIONAL, 2007, 20 : 301 - 301
  • [12] GENETIC IDENTIFICATION OF HOMOZOGOUS FAMILIAL HYPERCHOLESTEROLEMIA AMONG PATIENTS WITH CLINICALLY DIAGNOSED HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Chaudhry, Ahsen
    Vesely, Kristin
    Trinder, Mark
    Brunham, Liam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1473 - 1473
  • [13] Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
    Santos, Raul D.
    Wiegman, Albert
    Caprio, Sonia
    Cariou, Bertrand
    Averna, Maurizio
    Poulouin, Yann
    Scemama, Michel
    Manvelian, Garen
    Garon, Genevieve
    Daniels, Stephen
    JAMA PEDIATRICS, 2024, 178 (03) : 283 - 293
  • [14] Lipoprotein(a) metabolism in patients with heterozygous familial hypercholesterolemia
    Parhofer, KG
    Ritter, MM
    Geiss, C
    Schwandt, P
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 146 - 146
  • [15] Colesevelam: In pediatric patients with heterozygous familial hypercholesterolemia
    Perry C.M.
    Pediatric Drugs, 2010, 12 (2) : 133 - 140
  • [16] Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia 5-Year SAFEHEART Registry Follow-Up
    Perez de Isla, Leopoldo
    Alonso, Rodrigo
    Watts, Gerald F.
    Mata, Nelva
    Saltijeral Cerezo, Adriana
    Muniz, Ovidio
    Fuentes, Francisco
    Luis Diaz-Diaz, Jose
    de Andres, Raimundo
    Zambon, Daniel
    Rubio-Marin, Patricia
    Barba-Romero, Miguel A.
    Saenz, Pedro
    Sanchez Munoz-Torrero, Juan F.
    Martinez-Faedo, Ceferino
    Miramontes-Gonzalez, Jose P.
    Badimon, Lina
    Mata, Pedro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (11) : 1278 - 1285
  • [17] Statin Therapy and Risk of Diabetes Mellitus in Aging Patients With Heterozygous Familial Hypercholesterolemia or Familial Combined Hyperlipidemia: A 10-year Follow-up
    Ioakeimidis, Nikolaos
    Skoumas, John
    Vlachopoulos, Charalambos
    Terentes-Printzios, Dimitris
    Georgakopoulos, Christos
    Skliros, Nikitas
    Oikonomou, Evangelos
    Chrysohoou, Christina
    Tousoulis, Dimitris
    CIRCULATION, 2017, 136
  • [18] Statin Therapy and Risk of Diabetes Mellitus in Aging Patients With Heterozygous Familial Hypercholesterolemia or Familial Combined Hyperlipidemia: A 10-Year Follow-Up
    Skoumas, Ioannis
    Ioakeimidis, Nikolaos
    Vlachopoulos, Charalambos
    Chrysohoou, Christina
    Michalakeas, Christos
    Georgakopoulos, Christos
    Katsi, Vicky
    Panagiotakos, Demosthenes
    Tousoulis, Dimitrios
    ANGIOLOGY, 2018, 69 (03) : 242 - 248
  • [19] THE PREVALENCE OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN SELECTED REGIONS OF THE RUSSIAN FEDERATION
    Meshkov, A. N.
    Ershova, A. I.
    Shalnova, S. A.
    Drapkina, O. M.
    Boytsov, S. A.
    ATHEROSCLEROSIS, 2020, 315 : E9 - E10
  • [20] ONE YEAR FOLLOW-UP OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: PRELIMINARY DATA FROM THE HELLAS-FH REGISTRY
    Rizos, C.
    Liamis, G.
    Garoufi, A.
    Skoumas, I.
    Rallidis, L.
    Kolovou, G.
    Tziomalos, K.
    Skalidis, E.
    Kotsis, V.
    Lambadiari, V.
    Anagnostis, P. G.
    Dima, I.
    Kiouri, E.
    Kolovou, V.
    Polychronopoulos, G.
    Zacharis, E.
    Antza, C.
    Liberopoulos, E.
    ATHEROSCLEROSIS, 2022, 355 : E228 - E228